Pharmafile Logo

real-time data

Report fan imager

New report, The participation equation, uncovers key drivers of patient engagement in clinical trials

Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern clinical trials through insights from over 700 participants and industry experts.

Cuttsy + Cuttsy

- PMLiVE

BMS acquires Orbital Therapeutics in $1.5bn deal

The deal includes several next-gen cell therapy candidates for autoimmune diseases

- PMLiVE

Lilly and WHO Foundation partner to support global dementia action plan

The partnership will provide financial support and strengthen early detection and intervention efforts

- PMLiVE

Transforming pharma: the power of digital and AI engineering

Beyond flashy headlines about drug discovery lie less glamorous but highly effective AI applications

- PMLiVE

AstraZeneca to invest $4.5bn in US manufacturing facility

The investment will further support the company’s growing oncology pipeline

- PMLiVE

Breast Cancer Awareness Month marked as London’s King’s Cross tunnel lights up in pink

In the UK over 55,000 women and 400 men are diagnosed with breast cancer every year

- PMLiVE

Innovation, impact and the future: Communiqué Awards 2025

The themes were clear: innovation with purpose, enduring impact and a future in safe hands

Digital communications with the human touch: Doctor emerges from lap top computer screen

Are digital communications losing the human touch?

Are you looking to ensure digital communications for healthcare professionals and patients still include the human touch? Here's how.

Say Communications

- PMLiVE

La Roche-Posay launches global campaign to spotlight the visible and invisible impact of scars

‘Scars of Life’ aims to raise awareness of the psychological burden associated with skin conditions and scarring

- PMLiVE

Inizio announced as headline sponsor for 2026 Communiqué Awards

The PMGroup Awards celebrate excellence in health communications

- PMLiVE

Bioxodes appoints Philippe Monteyne as new chairman of the board

The appointment comes as the company releases phase 2a data for its intracerebral haemorrhage treatment

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links